Medpace Continues to Grow in Europe
News Aug 19, 2015
The new office is roughly three times the size of the former facility, allowing for significant growth in Data Management, Bio Statistics, Quality Assurance, Regulatory Affairs, Clinical Operations, and Safety. Together with the recently expanded London office, Medpace continues to invest in additional capacity for our operations globally. The UK offices in London and Stirling, Scotland, now houses close to 130 Medpace employees.
Medpace has focused expansion efforts in Europe over the past few years. The European activities have included adding additional clinical research professionals and expanding facilities in the United Kingdom, Poland, Russia, France, Germany and future significant office expansions planned for 2015/2016 in Leuven (Belgium), Prague (Czech Republic), Madrid (Spain). Medpace offices in Europe offer clinical operational support for a rapidly expanding Global and European market. Medpace established its first European office in the Czech Republic in 2005. Medpace employees in Europe now account for over one third of Medpace global employees.
With 12 European offices serving 30 EU countries, Medpace continues to grow and supply innovative support for studies in oncology, cardio metabolic, infectious disease, CNS, and other growing therapeutic areas. All European offices are fully integrated with Medpace global development services.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Hope for Hot Flushes: New Class of Menopause Drugs Reduces SeverityNews
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The new analysis, published in the journal Menopause, also revealed sleep and concentration significantly improved in the three-day window.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Clinical And Medical Microbiology
Sep 10 - Sep 11, 2018